Noninvasive Continuous Arterial Blood Pressure Monitoring with Nexfin®

Martina, Jerson R.; Westerhof, Berend E.; Goudoever, J. Van; Beaumont, E. M. F. H. de; Truijen, Jasper; Kim, Yu-Sok; Immink, Rogier V.; Jöbsis, D. A.; Hollmann, Markus W.; Lahpor, Jaap R.; Mol, Bas A.J.M. de; Lieshout, Johannes J. van

doi:10.1097/aln.0b013e31824f94ed

Cited by 258 publications

(201 citation statements)

References 29 publications

Supporting

Mentioning

195

Contrasting

Unclassified

Order By: Relevance

“…We did not perform a level of agreement analysis of our findings, obtained by the Nexfin monitor, with a gold standard. However, we and others previously showed that Nexfin arterial blood pressure and cardiac output showed good agreement with intra-arterial or oesophageal Doppler measurements [17,30,31].…”

Section: Discussionsupporting

confidence: 51%

Detection of volume loss using the Nexfin device in blood donors

et al. 2015

View full text Add to dashboard Cite

SummaryWe investigated which haemodynamic parameters derived from Nexfin non-invasive continuous arterial blood pressure measurements are optimal to detect controlled volume loss in spontaneously breathing subjects. Haemodynamic monitoring was performed in 40 whole-blood donors. Mean arterial pressure, cardiac index, systemic vascular resistance index and pulse pressure variation were recorded during controlled breathing, and a Valsalva manoeuvre was performed before and after blood donation. Blood donation resulted in a reduction in cardiac index (from 3.96 AE 0.84 l.min .m 2 ; p < 0.001) and an increase in pulse pressure variation (from 13.4 AE 5.1 to 15.3 AE 5.4%; p = 0.02). The area under the receiver operating characteristic curve to detect volume loss was highest for cardiac index (0.94, 95% CI 0.88-0.99) and systemic vascular resistance (0.90, 95% CI 0.82-0.99). Nexfin is a non-invasive haemodynamic monitor that can feasibly detect volaemic changes in spontaneously breathing subjects.

show abstract

Section: Discussionsupporting

confidence: 51%

Detection of volume loss using the Nexfin device in blood donors

et al. 2015

View full text Add to dashboard Cite

show abstract

“…The NICOM is a bioreactance-based monitor that has been shown to perform similarly to the ED in guiding GDFT [38]. The Nexfin accurately and continuously measures both arterial blood pressure [39] and CO [40,41] using an inflatable finger cuff.…”

Section: Does Gdft Improve Outcomes?mentioning

confidence: 99%

State-of-the-art fluid management in the operating room

Miller

Raghunathan

Gan

2014

Best Practice & Research Clinical Anaesthesiology

View full text Add to dashboard Cite

The underlying principles guiding fluid management in any setting are very simple: maintain central euvolemia, and avoid salt and water excess. However, these principles are frequently easier to state than to achieve. Evidence from recent literature suggests that avoidance of fluid excess is important, with excessive crystalloid use leading to perioperative weight gain and an increase in complications. A zero-balance approach aimed at avoiding fluid excess is recommended for all patients. For major surgery, there is a sizeable body of evidence that an individualized goal-directed fluid therapy (GDFT) improves outcomes. However, within an Enhanced Recovery program only a few studies have been published, yet so far GDFT has not achieved the same benefit. Balanced crystalloids are recommended for most patients. The use of colloids remains controversial; however, current evidence suggests they can be beneficial in intraoperative patients with objective evidence of hypovolemia.

show abstract

“…However, accuracy and precision are still debated (11). This case demonstrated ClearSight has potential to improve patient monitoring in hemodynamically stable patients who receive kidney transplantation under general anesthesia.However, further studies are needed to provide reliable information for the intraoperative management of high risk patients during renal transplantation without the need for invasive arterial cannulation and central venousr catheter.…”

Section: Discussionmentioning

confidence: 97%

Effectiveness of using non‐invasive continuous arterial pressure monitoring with ClearSight in hemodynamic monitoring during living renal transplantation in a recipient:a case report

et al. 2018

View full text Add to dashboard Cite

: We investigated the effectiveness of the ClearSight system for hemodynamic management during kidney transplantation for a recipient. The recipient was to receive a kidney transplant from his mother under general anesthesia. We used continuous noninvasive finger-cuff-based monitoring of blood pressure, provided by the ClearSight system, and stroke volume variation to predict fluid responsiveness. We used of a balanced anesthetic technique and stringent monitoring standards to ensure a successful outcome for the patient. This case demonstrated that ClearSight has the potential to improve patient monitoring in hemodynamically stable patients who received kidney transplantation under general anesthesia.

show abstract

Noninvasive Continuous Arterial Blood Pressure Monitoring with Nexfin®

Cited by 258 publications

References 29 publications

Detection of volume loss using the Nexfin device in blood donors

Detection of volume loss using the Nexfin device in blood donors

State-of-the-art fluid management in the operating room

Effectiveness of using non‐invasive continuous arterial pressure monitoring with ClearSight in hemodynamic monitoring during living renal transplantation in a recipient:a case report

Contact Info

Product

Resources

About